The Global Fund has awarded nearly US$1 billion to 106 countries to support their responses to COVID-19, but has now fully deployed all its funding for this purpose. There are significant further needs for immediate funding, including for personal pr...
The Global Fund praises Denmark, Norway and Sweden for allocating a total US$45 million to the Global Fund’s efforts to support low- and middle-income countries to fight COVID-19. Denmark, Norway and Sweden respectively pledged DKK 25 million, NOK 28...
The Global Fund applauds the government of Canada for allocating CAD 65 million to the Global Fund’s efforts to support low- and middle-income countries to fight COVID-19, including procuring and deploying millions of COVID-19 rapid diagnostics tests...
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed Tracy Staines, a distinguished auditor and seasoned executive, as Inspector General. Staines brings over 20 years of multi-sectoral experience in audit and risk manage...
The first co-financing investment under a new agreement between the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria, and the World Bank, will support the Government of the Lao People’s Democratic Republic’s goal of achieving universal health...
The German Federal Ministry of Economic Cooperation and Development and the Global Fund signed an additional contribution agreement of EUR150 million to mitigate the impact of COVID-19 in low- and middle-income countries, signaling a strong partnersh...
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria met virtually for the 44th Board meeting this week to discuss the organization’s response to the COVID-19 pandemic, development of the next Global Fund strategy and progress in the ...
The Global Fund and Chevron Corporation have celebrated a 12-year partnership that served as an example of the private sector’s contribution to the fight against infectious diseases and to building resilient health systems.
A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were today announced by the Access to COVID-19 Tools (ACT) Accelerator.
A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic.